You may also like

Just Snags $15M From Merck, Lilly, ARCH for Low-Cost Biotech Drugs
‘Pharmaphobia’ Pushes Back Against Anti-Industry Crusade, But Comes Up Short
Molecular Information Companies, One Way or Another, Find Value in Genomics
Data From Texas: VCs, Still Mostly Underwater, Ride Stocks As Long As Possible